Centessa CEO Trades Dual‑Side Play: Buys at $4, Sells at $28 – Insider Confidence Amid R&D‑Heavy Outlook
Insider trading reveals Centessa Pharma’s confidence: Karen Anderson buys low at $4, sells high at ~$28, balancing gains with long‑term investment while the company climbs 76% YTD. Explore what this signals for future upside and R&D milestones.
- Centessa Pharmaceuticals PLC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read